- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Orchid Pharma Limited — Important, 29-05-2025: Updates
29-05-2025 | 05:49 pm
29-05-2025 | 05:49 pm
Orchid Pharma received a USFDA Establishment Inspection Report with "Voluntary Action Indicated" status, reflecting acceptance of its corrective measures. This reinforces the company’s compliance with USFDA standards and supports its credibility in pharmaceutical manufacturing quality, potentially aiding future U.S. market opportunities.
No comments yet. Be the first to comment!